α-aryloxy-α-methylhydrocinnamic acids:: A novel class of PPARα/γ dual agonists.

被引：0

作者：

Xu, YP ^{[1
]}

Brooks, DA ^{[1
]}

Dominianni, SJ ^{[1
]}

Etgen, G ^{[1
]}

Jones, SB ^{[1
]}

Kauffman, RF ^{[1
]}

Montrose-Rafizadeh, C ^{[1
]}

Rito, CJ ^{[1
]}

Shuker, AJ ^{[1
]}

Tripp, A ^{[1
]}

Winneroski, LL ^{[1
]}

Zink, RW ^{[1
]}

McCarthy, J ^{[1
]}

机构：

[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 226卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

362-MEDI

引用

页码：U68 / U68

页数：1

共 50 条

[1] Design and synthesis of α-aryloxy-α-methylhydrocinnamic acids:: A novel class of dual peroxisome proliferator-activated receptor α/γ agonists
Xu, YP
Rito, CJ
Etgen, GJ
Ardecky, RJ
Bean, JS
Bensch, WR
Bosley, JR
Broderick, CL
Brooks, DA
Dominianni, SJ
Hahn, PJ
Liu, S
Mais, DE
Montrose-Rafizadeh, C
Ogilvie, KM
Oldham, BA
Peters, M
Rungta, DK
Shuker, AJ
Stephenson, GA
Tripp, AE
Wilson, S
Winneroski, LL
Zink, R
Kauffman, RF
McCarthy, JR
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (10) : 2422 - 2425
[2] Antitumor activity of a novel series of α-aryloxy-α-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines
Xishan Xiong
Yangliang Ye
Lili Fu
Bing Dai
Jieqiong Liu
Jieshuang Jia
Jing Tang
Lin Li
Li Wang
Jianhua Shen
Changlin Mei
[J]. Investigational New Drugs, 2009, 27 : 223 - 232
[3] Antitumor activity of a novel series of α-aryloxy-α-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines
Xiong, Xishan
Ye, Yangliang
Fu, Lili
Dai, Bing
Liu, Jieqiong
Jia, Jieshuang
Tang, Jing
Li, Lin
Wang, Li
Shen, Jianhua
Mei, Changlin
[J]. INVESTIGATIONAL NEW DRUGS, 2009, 27 (03) : 223 - 232
[4] Discovery of potent PPARα and PPARγ dual agonists.
Oplinger, JA
Spearing, PK
Collins, JL
Plunket, KD
Lewis, M
Oliver, W
Tong, T
Alva, G
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U42 - U42
[5] Novel Pirinixic Acids as PPARα Preferential Dual PPARα/γ Agonists
Zettl, Heiko
Dittrich, Michaela
Steri, Ramona
Proschak, Ewgenij
Rau, Oliver
Steinhilber, Dieter
Schneider, Gisbert
Laemmerhofer, Michael
Schubert-Zsilavecz, Manfred
[J]. QSAR & COMBINATORIAL SCIENCE, 2009, 28 (05): : 576 - 586
[6] Discovery of potent orally active aryloxazolidinediones class of dual PPAR gamma and alpha agonists.
Desai, RC
Gratale, DF
Han, W
Koyama, H
Metzger, E
Lombardo, VK
Berger, JP
MacNaul, KL
Doebber, TW
Zhou, GC
Leung, K
Franklin, R
Moller, DE
Sahoo, SP
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U176 - U177
[7] Design and synthesis of a novel class of dual PPARγ/δ agonists
Gonzalez, Isabel C.
Lamar, Jason
Iradier, Fatima
Xu, Yanping
Winneroski, Leonard L.
York, Jeremy
Yumibe, Nathan
Zink, Richard
Montrose-Rafizadeh, Chahrzad
Etgen, Gary J.
Broderick, Carol L.
Oldham, Brian A.
Mantlo, Nathan
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (04) : 1052 - 1055
[8] A novel, structurally unique class of muscarinic agonists.
Nason, DM
Lee, MH
Biggers, CK
Ward, KM
Nowakowski, JT
Yohannes, D
Liston, DR
Villalobos, A
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 81 - MEDI
[9] Design and synthesis of novel, potent, and selective PPAR delta agonists.
Conner, SE
Zhu, GX
Montrose-Rafizadeh, C
Barr, RJ
Jett, D
Zink, RW
Yumibe, N
Mantlo, NB
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U940 - U940
[10] Design, development and evaluation of novel dual PPARδ/PPARγ agonists
Gathiaka, Symon
Nanayakkara, Gayani
Boncher, Tracey
Acevedo, Orlando
Wyble, Johnathon
Patel, Sagar
Patel, Akash
Shane, Mary Elizabeth
Bonkowski, Blake
Wieczorek, Jason
Rong, Yinghui
Huggins, Kevin
Smith, Forest
Amin, Rajesh H.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (03) : 873 - 879

← 1 2 3 4 5 →